Factor D, Dale B. CURRENT CONCEPTS OF ROTATOR CUFF TENDINOPATHY. Int J Sports Phys Ther. 2014;9(2):274-288.
Magliacane D, Parente R, Triggiani M. Current Concepts on Diagnosis and Treatment of Mastocytosis. Transl Med UniSa. 2014;8:65-74.
Thomas X. Current indications of allogeneic stem cell transplant in adults with acute myeloid leukemia. Bull Cancer. 2014.
Orth P, Rey-Rico A, Venkatesan JK, Madry H, Cucchiarini M. Current perspectives in stem cell research for knee cartilage repair. Stem Cells Cloning. 2014;7:1-17.
Mariano EDomingos, Batista CMarquez, Barbosa BJosé Alen, Marie SKazue Naga, Teixeira MJacobsen, Morgalla M, Tatagiba M, Li J, Lepski G. Current perspectives in stem cell therapy for spinal cord repair in humans: a review of work from the past 10 years. Arq Neuropsiquiatr. 2014;72(6):451-456.
Smith RKw, Garvican ER, Fortier LA. The current 'state of play' of regenerative medicine in horses: what the horse can tell the human. Regen Med. 2014;9(5):673-685.
Kono K. Current status of cancer immunotherapy. J Stem Cells Regen Med. 2014;10(1):8-13.
Zhu T, Tang Q, Gao H, Shen Y, Chen L, Zhu J. Current status of cell-mediated regenerative therapies for human spinal cord injury. Neurosci Bull. 2014.
Kaminsky P, Lidove O. [Current therapeutic strategies in lysosomal disorders.]. Presse Med. 2014.
Avigan D, Rosenblatt J. Current Treatment for Multiple Myeloma. N Engl J Med. 2014;371(10):961-962.
Mravic M, Péault B, James AW. Current Trends in Bone Tissue Engineering. Biomed Res Int. 2014;2014:865270.
Ding G, Niu J, Wei F. Current understanding of orofacial tissue derived mesenchymal stem cells: an immunological perspective. Histol Histopathol. 2014.
Kmiecik G, Spoldi V, Silini A, Parolini O. Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues. Stem Cell Rev. 2014.
Miri-Moghaddam E, Sargolzaie N. Cut off Determination of Discrimination Indices in Differential Diagnosis between Iron Deficiency Anemia and β- Thalassemia Minor. Int J Hematol Oncol Stem Cell Res. 2014;8(2):27-32.
Oriss TB, Krishnamoorthy N, Raundhal M, Morse C, Chakraborty K, Khare A, Huff R, Ray P, Ray A. Cutting Edge: MMP-9 Inhibits IL-23p19 Expression in Dendritic Cells by Targeting Membrane Stem Cell Factor Affecting Lung IL-17 Response. J Immunol. 2014.
Uemae Y, Ishikawa E, Osuka S, Matsuda M, Sakamoto N, Takano S, Nakai K, Yamamoto T, Matsumura A. CXCL12 secreted from glioma stem cells regulates their proliferation. J Neurooncol. 2014.
Gil M, Komorowski MP, Seshadri M, Rokita H, McGray AJRobert, Opyrchal M, Odunsi KO, Kozbor D. CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells. J Immunol. 2014.
Hara T, Tanegashima K. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis. Biomol Concepts. 2014;5(2):167-173.
Jung J-H, Lee SJin, Kim JH, Lee SH, Sung H-J, An J, Park Y, Kim BSoo. CXCR2 and its related ligands play a novel role in supporting the pluripotency and proliferation of human pluripotent stem cells. Stem Cells Dev. 2014.
Zuk A, Gershenovich M, Ivanova Y, MacFarland RT, Fricker SP, Ledbetter SR. CXCR4 Antagonism as a Therapeutic Approach to Prevent Acute Kidney Injury. Am J Physiol Renal Physiol. 2014.
Melo Rde Cássia, Longhini ALeda, Bigarella CLouzão, Baratti MOzello, Traina F, Favaro P, Campos Pde Melo, Saad STeresinha. CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12. PLoS One. 2014;9(1):e85926.
Knott EP, Assi M, Pearse DD. Cyclic AMP Signaling: A Molecular Determinant of Peripheral Nerve Regeneration. Biomed Res Int. 2014;2014:651625.
Gellersen B, Brosens JJ. Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure. Endocr Rev. 2014:er20141045.
Bendris N, Cheung CT, Leong HSing, Lewis JD, Chambers AF, Blanchard JMarie, Lemmers B. Cyclin A2, a novel regulator of EMT. Cell Mol Life Sci. 2014.
Chen C-L, Wang L-J, Yan Y-T, Hsu H-W, Su H-L, Chang F-P, Hsieh PCH, Hwang S-M, Shen C-N. Cyclin D1 acts as a barrier to pluripotent reprogramming by promoting neural progenitor fate commitment. FEBS Lett. 2014.